CalciMedica is trading at $0.92 (+15.72%) in pre-market despite no fresh company-specific catalyst, earnings release, or FDA update being identified.
- The move represents a sharp rebound from the August 4 closing price of $0.80.
- The price action appears consistent with continued volatility and short-term trading activity following recent FDA-related swings rather than a shift in fundamentals.
- No new corporate announcements or regulatory filings have been reported to explain the current upward momentum.